Status:
NOT_YET_RECRUITING
White Cover & Massage Effects on Bilirubin and Phototherapy in ABO-Incompatible Newborns
Lead Sponsor:
Karabuk University
Conditions:
Newborn Jaundice
Hyperbilirubinemia, Neonatal
Eligibility:
All Genders
12-1 years
Phase:
NA
Brief Summary
This study aims to examine the effect of white cover and massage application on bilirubin levels and phototherapy duration in newborns with ABO incompatibility receiving phototherapy.
Detailed Description
Hyperbilirubinemia is a common problem seen in the neonatal period characterized by yellow staining of the skin and sclera, causing an increase in total serum bilirubin \>5 mg/dl. Neonatal jaundice is...
Eligibility Criteria
Inclusion
- Abo-Incompatibility term babies with a gestational age between 37-42 weeks,
- Does not have a respiratory, cardiovascular, gastrointestinal or neurological disorder or syndrome that would prevent or complicate oral feeding,
- Birth weight of 2500 g and above,
- With phototherapy indication,
- Do not have any health problems other than neonatal jaundice detected in the prenatal period,
- Those with a stable health condition,
- Orally fed,
- No clinical signs of dehydration,
- Do not have any skin problems that would prevent baby massage,
- Newborns with written and verbal informed consent from their families will be included in the study.
Exclusion
- Premature,
- Those with congenital malformations,
- Those with hyperbilirubinemia requiring exchange transfusion,
- Those with Rh hemolytic disease,
- Having a positive culture test (sepsis),
- Those with glucose-6-phosphate dehydrogenase (G6PD) deficiency,
- Birth weight below 2500 grams,
- Those who were referred to another center during the research,
- Discharged early,
- Unexpected complications developed during the research,
- Bronze child syndrome occurs during phototherapy,
- Newborns who develop a pathology that will prevent or complicate oral feeding will not be included in the study.
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 5 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06921330
Start Date
January 1 2026
End Date
March 5 2026
Last Update
January 6 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karabük Eğitim Ve Araştırma Hastanesi
Karabük, Karabük Province, Turkey (Türkiye), 78020